Entero Healthcare Delivers Strong Q2FY27 Earnings with 78% YoY EBITDA Growth
Entero Healthcare Solutions Ltd 路 Investor Presentation 路 05 Nov 2026, 3:32 am
Entero Healthcare Delivers Strong Q2FY27 Earnings with 78% YoY EBITDA Growth Entero Healthcare delivered strong Q2FY27 performance, with reported revenue growing 32.9% YoY to Rs. 2,087.1 Cr (34.7% LFL YoY), driven by 18.2% organic growth. Gross margin expanded 126 bps YoY to 11.5%, while EBITDA surged 78% YoY to Rs. 110.7 Cr, expanding margins by 135 bps YoY to 5.3%. PAT increased 66% YoY to Rs. 60.7 Cr. For H1FY27, revenue reached Rs. 4,027.6 Cr (+35% YoY) with PAT at Rs. 112.8 Cr. Annualized RoCE and RoE improved to 22.0% and 22.4%, respectively.
Original exchange filing (PDF)
More announcements from Entero Healthcare Solutions Ltd
- Transcript of Earnings Call / Conference Call 路 13 Nov 2026
- Recording of Earnings Call/ Conference Call on Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for 3P India Equity Fund 路 05 Nov 2026
- Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 路 05 Nov 2026
- Entero Healthcare Solutions Limited has informed the Exchange regarding Grant of 49712 Options. 路 05 Nov 2026
- Grant of fresh 49,712 (Forty-Nine Thousand Seven Hundred Twelve) Employee Stock Options under the existing 'Entero Employee Stock Option Plan 2023'. 路 05 Nov 2026
- Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 路 05 Nov 2026
- Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
